Clinical Trial Update: A Study of Abiraterone Acetate (JNJ-212082) and Prednisolone in Patients With Advanced Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial investigating abiraterone acetate with prednisolone in advanced prostate cancer has been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Abiraterone acetate (Abiraterone acetate)
• Prednisolone (Prednisolone)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-05-23